Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Debating clinical utility.

Burke W, Laberge AM, Press N.

Public Health Genomics. 2010;13(4):215-23. doi: 10.1159/000279623. Epub 2010 Apr 15.

2.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
3.

NIH consensus development conference draft statement on vaginal birth after cesarean: new insights.

Cunningham FG, Bangdiwala SI, Brown SS, Dean TM, Frederiksen M, Rowland Hogue CJ, King T, Spencer Lukacz E, McCullough LB, Nicholson W, Petit NF, Probstfield JL, Viguera AC, Wong CA, Zimmet SC.

NIH Consens State Sci Statements. 2010 Mar 10;27(3):1-42. Review.

4.

Personal genome testing: test characteristics to clarify the discourse on ethical, legal and societal issues.

Bunnik EM, Schermer MH, Janssens AC.

BMC Med Ethics. 2011 Jun 14;12:11. doi: 10.1186/1472-6939-12-11. Review.

5.

Ethical issues with newborn screening in the genomics era.

Tarini BA, Goldenberg AJ.

Annu Rev Genomics Hum Genet. 2012;13:381-93. doi: 10.1146/annurev-genom-090711-163741. Epub 2012 May 1. Review.

6.

Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.

Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C.

Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. Review.

7.

Newborn screening policy in the United Kingdom & the United States: two different communities of practice.

Patch C.

MCN Am J Matern Child Nurs. 2006 May-Jun;31(3):164-8. Review.

PMID:
16679957
8.

Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.

Wilfond BS, Parad RB, Fost N.

J Pediatr. 2005 Sep;147(3 Suppl):S109-13. Review.

PMID:
16202773
9.

A clinical perspective on ethical issues in genetic testing.

Sijmons RH, Van Langen IM, Sijmons JG.

Account Res. 2011 May;18(3):148-62. doi: 10.1080/08989621.2011.575033. Review.

PMID:
21574071
10.

The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.

Burch J, Hinde S, Palmer S, Beyer F, Minton J, Marson A, Wieshmann U, Woolacott N, Soares M.

Health Technol Assess. 2012;16(34):1-157, iii-iv. doi: 10.3310/hta16340. Review.

11.

Engaging patients in health care decisions in the emergency department through shared decision-making: a systematic review.

Flynn D, Knoedler MA, Hess EP, Murad MH, Erwin PJ, Montori VM, Thomson RG.

Acad Emerg Med. 2012 Aug;19(8):959-67. doi: 10.1111/j.1553-2712.2012.01414.x. Epub 2012 Jul 31. Review.

12.

[Neonatal screening: trends, debates and consensus].

Vailly J.

Med Sci (Paris). 2007 Mar;23(3):323-6. Review. French.

13.

Neonatal genetic testing is more than screening.

Kenner C, Lewis JA, Pressler JL, Little CM.

Crit Care Nurs Clin North Am. 2008 Jun;20(2):233-7, vii. doi: 10.1016/j.ccell.2008.01.005. Review.

PMID:
18424352
14.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

15.

Ethical decision making in first trimester pregnancy screening.

Zindler L.

J Perinat Neonatal Nurs. 2005 Apr-Jun;19(2):122-31; quiz 132-3. Review.

PMID:
15923961
16.

Evidence-based medicine beyond the bedside: keeping an eye on context.

Tilburt JC.

J Eval Clin Pract. 2008 Oct;14(5):721-5. doi: 10.1111/j.1365-2753.2008.00948.x. Review.

PMID:
19018902
17.

Health policy issues and applications for evidence-based medicine and clinical practice guidelines.

Lohr KN, Eleazer K, Mauskopf J.

Health Policy. 1998 Oct;46(1):1-19. Review.

PMID:
10187652
18.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

19.

Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.

Bishop Hubbard H.

Policy Polit Nurs Pract. 2007 Aug;8(3):201-9. doi: 10.1177/1527154407303498. Review.

PMID:
18178927
20.

A systematic review of patient-reported and economic outcomes: value to stakeholders in the decision-making process in patients with type 2 diabetes mellitus.

Vieta A, Badia X, Sacristán JA.

Clin Ther. 2011 Sep;33(9):1225-45. doi: 10.1016/j.clinthera.2011.07.013. Review.

PMID:
21856000
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk